1,801
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005–2016

, &
Pages 1807-1814 | Received 30 Nov 2017, Accepted 25 Feb 2018, Published online: 26 Mar 2018

References

  • Centers for Disease Control and Prevention. Shingles (herpes zoster). 2015. Available at: http://www.cdc.gov/shingles/index.html [accessed: 30 Jan 2018].
  • Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833. doi:10.1136/bmjopen-2014-004833. PMID:24916088.
  • Pinchinat S, Cebrian-Cuenca AM, Bricout H, Johnson RW. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis. 2013;13:170. doi:10.1186/1471-2334-13-170. PMID:23574765.
  • Johnson RW, Whitton TL. Management of herpes zoster (shingles) and postherpetic neuralgia. Expert Opin Pharmacother. 2004;5:551–9. doi:10.1517/14656566.5.3.551. PMID:15013924.
  • Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271–84. doi:10.1056/NEJMoa051016. PMID:15930418.
  • Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;28:954–9. doi:10.1097/INF.0b013e3181a90b16. PMID:19536039.
  • Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis. 2013;208:1859–68. doi:10.1093/infdis/jit405. PMID:23922376.
  • Hope-Simpson RE. The Nature of Herpes Zoster: A Long-Term Study and a New Hypothesis. Proc R Soc Med. 1965;58:9–20. PMID:14267505.
  • Alain S, Paccalin M, Larnaudie S, Perreaux F, Launay O. [Impact of routine pediatric varicella vaccination on the epidemiology of herpes zoster]. Med Mal Infect. 2009;39:698–706. doi:10.1016/j.medmal.2009.04.009. PMID:19574007.
  • Ogunjimi B, Van Damme P, Beutels P. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review. PLoS One. 2013;8:e66485. doi:10.1371/journal.pone.0066485. PMID:23805224.
  • Hecht J, Siedler A. [The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation : Analysis of mandatory and sentinel data between 2002 and 2014]. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz. 2017;60:118–26. doi:10.1007/s00103-016-2475-8..
  • Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Stand: Juli 2004. Epidemiologisches Bulletin. 2004;30:235–50.
  • Robert Koch-Institut. Begründung der STIKO für eine allgemeine Varizellenimpfung. Epidemiologisches Bulletin. 2004;49:421–3..
  • Robert Koch-Institut. Mitteilung der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Impfung gegen Varizellen im Kindesalter: Empfehlung einer zweiten Varizellenimpfung. Empfehlung und Begründung. Epidemiologisches Bulletin. 2009;32:328–36..
  • Hillebrand K, Bricout H, Schulze-Rath R, Schink T, Garbe E. Incidence of herpes zoster and its complications in Germany, 2005–2009. J Infect. 2015;70:178–86. doi:10.1016/j.jinf.2014.08.018. PMID:25230396.
  • Ultsch B, Siedler A, Rieck T, Reinhold T, Krause G, Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis. 2011;11:173. doi:10.1186/1471-2334-11-173. PMID:21679419.
  • Schiffner-Rohe J, Jow S, Lilie HM, Koster I, Schubert I. [Herpes zoster in Germany. A retrospective analyse of SHL data]. MMW Fortschr Med. 2010;151 Suppl 4:193–7..
  • Paul E, Thiel T. [Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area]. Hautarzt. 1996;47:604–9.
  • Horn J, Karch A, Damm O, Kretzschmar ME, Siedler A, Ultsch B, Weidemann F, Wichmann O, Hengel H, Greiner W, et al. Current and future effects of varicella and herpes zoster vaccination in Germany – Insights from a mathematical model in a country with universal varicella vaccination. Hum Vaccin Immunother. 2016;12:1766–76. PMID:26835890.
  • Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother. 2014;10:3594–600. doi:10.4161/hv.34426. PMID:25483695.
  • Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine. 2010;28:2532–8. doi:10.1016/j.vaccine.2010.01.036. PMID:20117265.
  • Grant KA, Carville KS, Kelly HA. Evidence of increasing frequency of herpes zoster management in Australian general practice since the introduction of a varicella vaccine. Med J Aust. 2010;193:483. PMID:20955129.
  • MacIntyre R, Stein A, Harrison C, Britt H, Mahimbo A, Cunningham A. Increasing trends of herpes zoster in Australia. PLoS One. 2015;10(4):e0125025. doi:10.1371/journal.pone.0125025. PMID:25928713.
  • Russell ML, Dover DC, Simmonds KA, Svenson LW. Shingles in Alberta: before and after publicly funded varicella vaccination. Vaccine. 2014;32:6319–24. doi:10.1016/j.vaccine.2013.09.018. PMID:24099868.
  • Wu PY, Wu HD, Chou TC, Sung FC. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One. 2013;8:e77709. doi:10.1371/journal.pone.0077709. PMID:24204928.
  • Esteban-Vasallo MD, Gil-Prieto R, Dominguez-Berjon MF, Astray-Mochales J, Gil de Miguel A. Temporal trends in incidence rates of herpes zoster among patients treated in primary care centers in Madrid (Spain), 2005–2012. J Infect. 2014;68:378–86. doi:10.1016/j.jinf.2013.09.035. PMID:24247069.
  • Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008. Epidemiol Infect. 2012;140:1131–40. doi:10.1017/S0950268811001786. PMID:21906410.
  • Civen R, Marin M, Zhang J, Abraham A, Harpaz R, Mascola L, Bialek SR. Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010. Pediatr Infect Dis J. 2016;35:1132–6. doi:10.1097/INF.0000000000001249..
  • Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med. 2013;159:739–45. doi:10.7326/0003-4819-159-11-201312030-00006. PMID:24297190.
  • Kawai K, Yawn BP, Wollan P, Harpaz R. Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. Clin Infect Dis. 2016;63:221–6. doi:10.1093/cid/ciw296. PMID:27161774.
  • Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination. Clin Infect Dis. 2011;52:332–40. doi:10.1093/cid/ciq077. PMID:21217180.
  • Rimland D, Moanna A. Increasing incidence of herpes zoster among Veterans. Clin Infect Dis. 2010;50:1000–5. doi:10.1086/651078. PMID:20178416.
  • Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, Seward JF. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health. 2005;5:68. doi:10.1186/1471-2458-5-68. PMID:15960856.
  • Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marin-Garcia P, Gil-de-Miguel A. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine. 2014;32:277–83. doi:10.1016/j.vaccine.2013.11.008. PMID:24275483.
  • Ogunjimi B, Van den Bergh J, Meysman P, Heynderickx S, Bergs K, Jansen H, Leuridan E, Vorsters A, Goossens H, Laukens K, et al. Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox. Sci Rep. 2017;7:1077. doi:10.1038/s41598-017-01024-8. PMID:28439065.
  • Godeaux O, Kovac M, Shu D, Grupping K, Campora L, Douha M, Heineman TC, Lal H. Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults >/ = 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial. Hum Vaccin Immunother. 2017;13:1051–8.
  • Siedler A, Koch J, Ultsch B, Garbe E, von Kries R, Ledig T, et al. Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany. Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI). Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz. 2017;60:1162–79.
  • Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J Infect Dis. 2005;191:2002–7. doi:10.1086/430325. PMID:15897984.
  • Chun C, Weinmann S, Riedlinger K, Mullooly JP, Houston H, Schmid DS, Seward JF. Laboratory characteristics of suspected herpes zoster in vaccinated children. Pediatr Infect Dis J. 2011;30:719–21. doi:10.1097/INF.0b013e3182137e35. PMID:21346684.
  • Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med. 1991;325:1545–50..
  • Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill. 2010;15(13). pii: 19530..
  • Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet. 1994;343:1548–51. doi:10.1016/S0140-6736(94)92943-2. PMID:7802767.
  • Kurlan JG, Connelly BL, Lucky AW. Herpes zoster in the first year of life following postnatal exposure to varicella-zoster virus: four case reports and a review of infantile herpes zoster. Arch Dermatol. 2004;140:1268–72. doi:10.1001/archderm.140.10.1268. PMID:15492192.
  • Robert Koch-Institut. Zur Sentinel-Surveillance der Varizellen in Deutschland. Epidemiologisches Bulletin. 2008;8:61–5..
  • Uphoff H, Stilianakis N. Ein Ansatz zur bevölkerungsbezogenen Auswertung der deutschen Influenza-Sentineldaten. Bundesgesundheitsbl – Gesundheitsforsch – Gesundheitsschutz. 2000;43:796–801. doi:10.1007/s001030050359..
  • The Information System of the Federal Health Monitoring. Employees and Facilities of Healthcare: Physicians, Treatment by Physicians 2017. Available at: http://www.gbe-bund.de/gbe10/trecherche.prc_them_rech?tk = 14501&tk2 = 15352&p_uid = gast&p_aid = 88075780&p_sprache = D&cnt_ut = 17&ut = 15401 [accessed: 30 May 2017].
  • Federal Statistical Office (Destatis). Population: Federal states, reference date, sex, age. 2017. Available at: https://www-genesis.destatis.de/genesis/online/data;jsessionid=2B7D96F52ED3EE5DB307D1EF3F4543F7.tomcat_GO_1_2?operation=abruftabelleAbrufen&selectionname=12411-0012&levelindex=1&levelid=1517990639496&index=12 [accessed: 30 May 2017].
  • Federal Statistical Office (Destatis). Hospital statistics: Diagnoses of hospital in-patients. 2017. Available at: https://www-genesis.destatis.de/genesis/online/data;jsessionid=F5EE68972F39D02EE21790E1D5F95B11.tomcat_GO_1_2?operation=abruftabelleAbrufen&selectionname=23131-0011&levelindex=1&levelid=1496135302745&index=8 [accessed: 30 May 2017].
  • Eurostat Task Force. European Standard Population (ESP) 2013. Luxembourg: European Union, 2017. Available at: http://www.causesofdeath.org/docs/standard.pdf [accessed: 30 May 2017].